Pharmaceutical Pricing: How Much for The Risk Of Non-Cure? (CROSBI ID 639963)
Prilog sa skupa u časopisu | sažetak izlaganja sa skupa
Podaci o odgovornosti
Mance, Davor ; Mance, Diana ; Vitezić, Dinko
engleski
Pharmaceutical Pricing: How Much for The Risk Of Non-Cure?
Pharmacoeconomics is a blend of economic methodology with clinical pharmacology and outcomes research with an objective to provide for more efficient and cost-effective treatments. By doing this, pharmacoeconomics is constantly faced with ethical decision-making problems. The problem lies with the attempt of using epistemologically objective methods on an intrinsically ontologically subjective subject matter. In this work we discuss the possibility of an epistemologically objective methodology of integration of measures of risk of non-cure into pharmaceutical pricing schemes.
Pharmacoeconomics ; Pharmaceutical Pricing ; Risk Of Non-Cure ; Sustained Virological Response
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
17-18.
2016.
nije evidentirano
objavljeno
10.1016/j.clinthera.2016.07.128
Podaci o matičnoj publikaciji
Clinical therapeutics
Elsevier
0149-2918
Podaci o skupu
European Association for Clinical Pharmacology and Therapeutics (EACPT) Focus Meeting 2016: How to Assess Medicines from Research to Clinical Practice? Efficacy, Effectiveness, and Economic– 3E Assessment
predavanje
06.10.2016-09.10.2016
Opatija, Hrvatska
Povezanost rada
Matematika, Kliničke medicinske znanosti, Ekonomija